Consumption of c9,t11-18:2 or t10,c12-18:2 enriched dietary supplements does not influence milk macronutrients in healthy, lactating women.
Substantial research suggests that the t10,c12-18:2, but not the c9,t11-18:2, isomer of conjugated linoleic acid (CLA) reduces milk fat synthesis in lactating bovine and rodent species. Because fat is the major energy-yielding component in human milk, we were interested in whether this is true for women as well. Thus, the effects of c9,t11-18:2 and t10,c12-18:2 on milk fat were examined in breast-feeding women (n = 12) in a double-blind, placebo-controlled, crossover study with latin-square design. The study was divided into six periods: baseline (3 days), three intervention periods (5 days each), and two washout periods (9 days each). During each intervention period, women consumed 750 mg/day of a supplement containing predominantly c9,t11-18:2, t10,c12-18:2, or 18:1 (olive oil placebo). Milk was collected by complete breast expression on the final day of each period. Infant milk consumption was estimated by 24 h weighing on the penultimate day of each intervention and washout period, and maternal adiposity (% body fat) was determined at baseline using dual energy X-ray absorptiometry. Milk c9,t11-18:2 and t10,c12-18:2 concentrations were greater (P < 0.05) during the corresponding CLA treatment periods as compared to the placebo period, providing strong evidence of subject compliance. Both CLA isomers were transferred into milk fat at relatively high efficiency; average transfer efficiency was estimated to be 23.3%. Compared to the placebo treatment, milk fat content was not reduced during either CLA treatment. Data indicate that body fatness did not modify any putative effect of isomeric CLA consumption on milk fat concentration. The evidence from this study suggests that the sensitivity of lactating women's mammary tissue to an anti-lipogenic effect of the t10,c12-18:2 isoform of CLA may be less than previously hypothesized.
Hasin
Afroza
A
Department of Food Science and Human Nutrition, Washington State University, Pullman, WA 99164-6376, USA.
Griinari
J Mikko
JM
Williams
Janet E
JE
Shahin
Alam M
AM
McGuire
Mark A
MA
McGuire
Michelle K
MK
D000273:Adipose Tissue / Q000502:physiology; D000328:Adult; D019587:Dietary Supplements; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007774:Lactation / Q000187:drug effects*; D044243:Linoleic Acids, Conjugated / Q000008:administration & dosage* / Q000494:pharmacology; D008895:Milk, Human / Q000737:chemistry*; D013237:Stereoisomerism
D044243:Linoleic Acids, Conjugated; C503589:cis-9, trans-11-conjugated linoleic acid; C496197:trans-10,cis-12-conjugated linoleic acid
Am J Clin Nutr. 1991 Jul;54(1):69-80
2058590
J Dairy Sci. 1999 Dec;82(12):2737-45
10629821
J Dairy Sci. 2006 May;89(5):1525-32
16606723
Br J Nutr. 2003 Dec;90(6):1039-48
14641963
Pediatr Clin North Am. 2001 Feb;48(1):53-67
11236733
Lipids. 2002 Feb;37(2):133-8
11908905
J Lipid Res. 1982 Sep;23(7):1072-5
6897259
Lipids. 1999 Jun;34(6):543-9
10405966
J Pediatr Gastroenterol Nutr. 1993 Oct;17(3):283-90
8271128
J Pediatr Gastroenterol Nutr. 1990 Aug;11(2):229-39
2395063
J Dairy Sci. 2004 May;87(5):1196-202
15290967
J Nutr. 1998 Feb;128(2 Suppl):394S-399S
9478034
J Chromatogr B Biomed Appl. 1995 Apr 7;666(1):1-12
7655607
J Nutr. 2005 Mar;135(3):416-21
15735072
Am J Physiol Regul Integr Comp Physiol. 2000 Jan;278(1):R179-84
10644637
J Nutr. 2001 May;131(5):1548-54
11340114
Am J Clin Nutr. 1991 Feb;53(2):457-65
1989413
J Mammary Gland Biol Neoplasia. 1999 Jul;4(3):285-95
10527470
Lipids. 2005 Aug;40(8):823-32
16296401
Lipids. 2004 Apr;39(4):365-72
15357024
J Lipid Res. 1987 Oct;28(10):1185-92
3681142
Lipids. 2007 Aug;42(8):723-9
17610100